Human Myxovirus Resistance Protein 1 (MxA) as a useful marker in the differential diagnosis of subcutaneous lymphoma vs. lupus erythematosus profundus

European Journal of Dermatology

Volumn 22, Issue 5, 2012, Pages 629-633

  Wang, Xuan ^a   Magro, Cynthia M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Interferon alpha; Lupus profundus erythematosus; MxA; Primary cutaneous gamma delta T cell lymphoma; Subcutaneous panniculitis like T cell lymphoma

Indexed keywords

ALPHA INTERFERON; MYXOVIRUS RESISTANCE PROTEIN; MYXOVIRUS RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS PROFUNDUS; LYMPHOCYTE; MACROPHAGE; PRIMARY CUTANEOUS GAMMA DELTA T CELL LYMPHOMA; SKIN BIOPSY; SUBCUTANEOUS T CELL LYMPHOMA;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, CUTANEOUS; MACROPHAGES; PANNICULITIS; PANNICULITIS, LUPUS ERYTHEMATOSUS; SKIN NEOPLASMS;

EID: 84868298621     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1790     Document Type: Article

References (30)

1. Magro CM, Crowson AN, Kovatich AJ, Burns F. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia. J Cutan Pathol 2001; 28: 235-47.
2. Guitart J. Subcutaneous lymphoma and related conditions. Dermatol Ther 2010; 23: 350-5.
3. Aguilera P, Mascaro JM Jr., Martinez A, et al. Cutaneous gamma/delta T-cell lymphoma: a histopathologic mimicker of lupus erythematosus profundus (lupus panniculitis). J Am Acad Dermatol 2007; 56: 643-7.
4. Pincus LB, LeBoit PE, McCalmont TH, et al. Subcutaneous panniculitis-like T-cell lymphoma with overlapping clinicopathologic features of lupus erythematosus: coexistence of 2 entities? Am J Dermatopathol 2009; 31: 520-6.
5. Gonzalez EG, Selvi E, Lorenzini S, et al. Subcutaneous panniculitislike T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis. Clinical rheumatology 2007; 26: 244-6.
6. Ma L, Bandarchi B, Glusac EJ. Fatal subcutaneous panniculitis-like Tcell lymphoma with interface change and dermal mucin, a dead ringer for lupus erythematosus. J Cutan Pathol 2005; 32: 360-5.
7. Cassis TB, Fearneyhough PK, Callen JP. Subcutaneous panniculitislike T-cell lymphoma with vacuolar interface dermatitis resembling lupus erythematosus panniculitis. J Am Acad Dermatol 2004; 50: 465-9.
8. Ronnblom L, Alm GV, Eloranta ML. The type I interferon system in the development of lupus. Semin Immunol 2011; 23: 113-21.
9. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159: 237-43.
10. Wenzel J, Proelss J, Wiechert A, Zahn S, Bieber T, Tuting T. CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. J Am Acad Dermatol 2007; 56: 648-50.
11. Wenzel J, Zahn S, Mikus S, Wiechert A, Bieber T, Tuting T. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br J Dermatol 2007; 157: 752-7.
12. Fah J, Pavlovic J, Burg G. Expression of MxA protein in inflammatory dermatoses. J Histochem Cytochem 1995; 43: 47-52.
13. Haller O, Kochs G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 2011; 31: 79-87.
14. Pletneva LM, Haller O, Porter DD, Prince GA, Blanco JC. Interferon-inducible Mx gene expression in cotton rats: cloning, characterization, and expression during influenza viral infection. J Interferon Cytokine Res 2006; 26: 914-21.
15. Holzinger D, Jorns C, Stertz S, et al. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 2007; 81: 7776-85.
16. Ghoreishi M, Martinka M, Dutz JP. Type 1 interferon signature in the scalp lesions of alopecia areata. Br J Dermatol 2010; 163: 57-62.
17. Nordborg C, Larsson K, Aman P, Nordborg E. Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis. Scand J Rheumatol 2009; 38: 144-8.
18. Millonig A, Dressel A, Bahner D, et al. MxA protein-an interferon beta biomarker in primary progressive multiple sclerosis patients. Eur J Neurol 2008; 15: 822-6.
19. Gilli F, Marnetto F, Caldano M, et al. Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. Mult Scler 2006; 12: 47-57.
20. Wenzel J, Worenkamper E, Freutel S, et al. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 2005; 205: 435-42.
21. Magro CM, Segal JP, Crowson AN, Chadwick P. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis. J Cutan Pathol 2010; 37: 659-71.
22. Gonzalez CL, Medeiros LJ, Jaffe ES. Delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med 1992; 326: 1088-9.
23. Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991; 15: 17-27.
24. Wenzel J, Zahn S, Bieber T, Tuting T. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus. Arch Dermatol Res 2009; 301: 83-6.
25. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. Apmis 1995; 103: 161-79.
26. Crow MK, Kirou KA, Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 2003; 36: 481-90.
27. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610-5.
28. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007; 8: 492-502.
29. Salloum R, Niewold TB. Interferon regulatory factors in human lupus pathogenesis. Transl Res 2011; 157: 326-31.
30. Sarris AH, Daliani D, Ulmer R, et al. Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas. Leuk Lymphoma 1996; 24: 103-10.